The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Saizen 5.83 mg/ml Solution for Injection

5.83 milligram(s)/millilitre Solution for injection

Merck Serono (Ireland) LimitedPA2286/006/001

Main Information

Trade NameSaizen 5.83 mg/ml Solution for Injection
Active SubstancesSomatropin
Strength5.83 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderMerck Serono (Ireland) Limited
Licence NumberPA2286/006/001

Group Information

ATC CodeH01AC Somatropin and somatropin agonists
H01AC01 somatropin

Status

Authorised/WithdrawnAuthorised
Licence Issued25/02/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2)
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back